Journal
BIOMATERIALS
Volume 29, Issue 7, Pages 825-833Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2007.10.044
Keywords
vascular tissue engineering; muscle-derived stem cells; scaffolds; vascular grafts; cell seeding; dynamic culture
Funding
- NHLBI NIH HHS [R01 HL069368, R01 HL069368-05] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069368] Funding Source: NIH RePORTER
Ask authors/readers for more resources
There is a clinical need for a tissue-engineered vascular graft (TEVG), and combining stem cells with biodegradable tubular scaffolds appears to be a promising approach. The goal of this study was to characterize the incorporation of muscle-derived stem cells (MDSCs) within tubular poly(ester urethane) urea (PEUU) scaffolds in vitro to understand their interaction, and to evaluate the mechanical properties of the constructs for vascular applications. Porous PEUU scaffolds were seeded with MDSCs using our recently described rotational vacuum seeding device, and cultured inside a spinner flask for 3 or 7 days. Cell viability, number, distribution and phenotype were assessed along with the suture retention strength and uniaxial mechanical behavior of the TEVGs. The seeding device allowed rapid even distribution of cells within the scaffolds. After 3 days, the constructs appeared completely populated with cells that were spread within the polymer. Cells underwent a population doubling of 2.1-fold, with a population doubling time of 35h. Stem cell antigen-1 (Sca-1) expression by the cells remained high after 7 days in culture (77 +/- 20% vs. 66 +/- 6% Lit day 0) while CD34 expression was reduced (19 +/- 12% vs. 61 +/- 10% at day 0) and myosin heavy chain expression was scarce (not quantified). The estimated burst strength of the TEVG constructs was 2127 +/- 900mmHg and suture retention strength was 1.3 +/- 0.3 N. We conclude from this study that MDSCs can be rapidly seeded within porous biodegradable tubular scaffolds while maintaining cell viability and high proliferation rates and without losing stem cell phenotype for tip to 7 days of in-vitro Culture. The successful integration of these steps is thought necessary to provide rapid availability of TEVGs, which is essential for clinical translation. (c) 2007 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available